FDA Approved: FEMARA — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved a supplemental application for FEMARA (letrozole) from Novartis Pharmaceuticals Corporation, updating the labeling for breast cancer use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• FEMARA (letrozole)

Snippet

SUPPL AP for FEMARA (LETROZOLE)